Results 11 to 20 of about 53,065 (244)

Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome

open access: bronzeGastroenterology, 1980
The effect of intravenous somatostatin infusion was investigated in a patient with severe secretory diarrhea due to malignant carcinoid syndrome. Continuous somatostatin infusion for 48 hr (4 microgram/kg/hr) reduced stool volume from 2.2 to 0.7 liters ...
Glenn R. Davis   +3 more
semanticscholar   +4 more sources

A Case of Carcinoid Syndrome Due to Malignant Metastatic Carcinoid Tumor with Carcinoid Heart Disease Involving Four Cardiac Valves [PDF]

open access: greenThe American journal of case reports, 2018
Patient: Female, 62 Final Diagnosis: Carcinoid heart disease Symptoms: Abdominal discomfort • diarrhea • fatigue • weight loss Medication: — Clinical Procedure: — Specialty: Cardiology Objective: Rare disease Background: Carcinoid tumor, benign, low ...
Brianna Shinn   +2 more
openalex   +2 more sources

Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR [PDF]

open access: bronzeAlimentary Pharmacology and Therapeutics, 2009
Christos Toumpanakis   +7 more
openalex   +2 more sources

Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel) [PDF]

open access: bronzeAlimentary Pharmacology and Therapeutics, 2011
Mohid S. Khan   +4 more
openalex   +2 more sources

Sandostatin LAR (long‐acting octreotide acetate) for malignant carcinoid syndrome: a 3‐year experience [PDF]

open access: bronzeAlimentary Pharmacology and Therapeutics, 2003
J. Garland   +7 more
openalex   +2 more sources

The Malignant Carcinoid Syndrome [PDF]

open access: yesCirculation, 1959
A. C. Corcoran   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy